{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/391863108"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "requirements or delays or other problems with existing or new products could result in increased costs, losses of sales and potential breaches of customer contracts, which could affect our operating results and revenues. 24 Successful commercialization of pharmaceutical products and product line extensions is very difficult and" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "sec.gov" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/223135962"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/391863108" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/223335523"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/391863108" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/138641931"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/391863108"] } } }
